Derek Cole of ARCA biopharma is focused on implementing NIRI's new strategic plan
| Tweet |
The newly elected chairman of the NIRI board of directors, Derek Cole, says his top priority for his one-year term will be to initiate implementation of the NIRI strategic plan, due to be voted on and released by the end of this year.
Cole is vice president of IR and ...
Register now to read the rest of this article! Registration is free and you will be able to read five articles every month.
Become a subscriber for unlimited access.
Ipreo: Global Equity Assets Report - Q4 2011
Dix & Eaton: Are you ready for the public?